Stockreport

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

Immunome, Inc.  (IMNM) 
PDF MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completio [Read more]